Key result
Salvia miltiorrhiza injection dose-dependently attenuated myocardial fibrosis in chronic iron-overloaded mice, reducing myocardial hydroxyproline content from 1.17 to /mg at the high dose.
Why the study?
Does Salvia miltiorrhiza attenuate myocardial fibrosis in mice with chronic iron overload?
Does Salvia miltiorrhiza attenuate myocardial fibrosis in mice with chronic iron overload?
Answers are grounded in this paper and cite their sources.
Salvia miltiorrhiza attenuates cardiac fibrosis and oxidative stress in a mouse model of chronic iron overload cardiomyopathy.
Iron overload cardiomyopathy results from iron accumulation in the myocardium that is closely linked to iron-mediated myocardial fibrosis. Salvia miltiorrhiza (SM, also known as Danshen), a traditional Chinese medicinal herb, has been widely used for hundreds of years to treat cardiovascular diseases. Here, we investigated the effect and potential mechanism of SM on myocardial fibrosis induced by chronic iron overload (CIO) in mice. Kunming male mice (8 weeks old) were randomized to six groups of 10 animals each: control (CONT), CIO, low-dose SM (L-SM), high-dose SM (H-SM), verapamil (VRP) and deferoxamine (DFO) groups. Normal saline was injected in the CONT group. Mice in the other five groups were treated with iron dextran at 50 mg/kg per day intraperitoneally for 7 weeks, and those in the latter four groups also received corresponding daily treatments, including 3 g/kg or 6 g/kg of SM, 100 mg/kg of VRP, or 100 mg/kg of DFO. The iron deposition was estimated histologically using Prussian blue staining. Myocardial fibrosis was determined by Masson's trichrome staining and hydroxyproline (Hyp) quantitative assay. Superoxide dismutase (SOD) activity, malondialdehyde (MDA) content and protein expression levels of type I collagen (COL I), type I collagen (COL III), transforming growth factor-β1 (TGF-β1) and matrix metalloproteinase-9 (MMP-9) were analyzed to investigate the mechanisms underlying the effects of SM against iron-overloaded fibrosis. Treatment of chronic iron-overloaded mice with SM dose-dependently reduced iron deposition levels, fibrotic area percentage, Hyp content, expression levels of COL I and COL III, as well as upregulated the expression of TGF- β1 and MMP-9 proteins in the heart. Moreover, SM treatment decreased MDA content and increased SOD activity. In conclusion, SM exerted activities against cardiac fibrosis induced by CIO, which may be attributed to its inhibition of iron deposition, as well as collagen metabolism and oxidative stress.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2015) studied Chronic iron overload-induced myocardial fibrosis (n=60). Salvia miltiorrhiza (SM) Injection vs. Chronic iron overload (CIO) with normal saline was evaluated on Myocardial hydroxyproline (Hyp) content (μg/mg) (p=<0.01). Salvia miltiorrhiza injection dose-dependently attenuated myocardial fibrosis in chronic iron-overloaded mice, reducing myocardial hydroxyproline content from 1.17 to /mg at the high dose.
Synapse has enriched 10 related papers. Consider them for comparative context: